Dr. Chris Stout is a licensed clinical psychologist and international humanitarian with a diverse background in various domains. He is the Founding Director of the Center for Global Initiatives (a Top-Rated Nonprofit) and is the Executive Producer and Host of the popular “Living a Life in Full” a top-ranked podcast with an audience of over 3 million. He was a Fellow in the School of Public Health and Full Professor in the Department of Psychiatry in the College of Medicine at the University of Illinois, Chicago and prior to that he held an academic appointment at Northwestern University’s Feinberg School of Medicine. He served as a NGO Special Representative and had the honor of speaking at the United Nations; he holds the distinction of being one of only 100 world-wide leaders appointed to the World Economic Forum’s Global Leaders of Tomorrow and was an Invited Faculty at the Annual Meeting in Davos. Dr. Stout is a worldwide speaker, organizational consultant and startup whisperer having worked or traveled in all 50 states, over 100 countries and 6 continents. He was noted as being “one of the most frequently cited psychologists in the scientific literature.” He is a Fellow in the American Psychological Association, past-President of the Illinois Psychological Association, and is a Distinguished Practitioner in the National Academies of Practice. He is a Best-Selling Author, having published 38 books. His works have been translated into 8 languages. He is a recipient of four Humanitarian Awards and four additional honorary doctorates. He is a popular LinkedIn Top Voice nearing a half-million followers and has been a guest on CNBC, CNN, NBC, PBS, NPR, and Oprah. He was listed in Fast Co.’s Global Fast 50 nominees and in TED Founder Richard Saul Wurman’s “Who’s Really Who.” His professional archive was deeded to the Smithsonian’s Museum for the History of Psychology. He balances all his academic and humanitarian efforts with time with his family, adventure sports, and mountaineering (having climbed 3 of the world’s 7 Summits)

Dr. Tran is the Chairman and Chief Executive Officer of Biomed Industries, Inc., a leading biotechnology company dedicated to developing breakthrough treatments for neurodegenerative and metabolic diseases. Dr. Tran has over 30 years of experience in pharmaceutical research and development, specializing in treatments for neurodegenerative diseases, metabolic disorders, and infectious diseases. He began his career as a scientist at G.D. Searle (later acquired by Monsanto) and Pfizer before serving as Director of Research & Development at Controlled Release Technology, Inc. Dr. Tran served as the Chief Scientific Officer for Biomed Pharmaceutical, Inc, and NeuroActiva, Inc. which was acquired by Biomed Industries, Inc. A pioneer in Alzheimer’s disease research, Dr. Tran was the first to identify the role of neurogenesis in its treatment. He holds multiple U.S. and international patents covering drugs targeting Alzheimer's disease, major depressive disorder, stroke, Rett syndrome, obesity, and Metabolic dysfunction-associated steatohepatitis (MASH). Dr. Tran has also contributed to global health initiatives, collaborating with Nobel laureate Dr. Tu Youyou in the development of Artemether for malaria treatment. Artemether plus lumefantrine (AL) is now approved in the U.S. and 86 countries worldwide. Additionally, he is the inventor of the MICROS Infusion System, which has been approved for marketing in the U.S. Beyond his scientific contributions, Dr. Tran serves as the Committee Chair of the Alzheimer’s International Society and has played a key role in advancing Alzheimer’s research. He holds a B.Sc. (Honours) in Chemistry from the University of Otago and a Ph.D. in Medicinal Chemistry from the University of Wellington, New Zealand.

Dr. Agostinho Francisco Leite D’Almeida is a retired lecturer from UMAIA (University of Maia), where he taught Psychology and Criminology, and remains active as a researcher in the fields of Neuropsychology, Neurosciences, and Criminology. He also serves as a visiting lecturer at the University of Fernando Pessoa in Porto, Portugal. With a multidisciplinary academic background spanning Philosophy, Sociology, Psychology, and Neurosciences, Dr. Leite D’Almeida has engaged in clinical practice and academic supervision for decades. He is also the Editor-in-Chief of the Journal of Forensic Psychology and holds advanced training and certification in clinical neuropsychology, psychotherapy, and sexology.

For over three decades Nagy has been at the forefront of clinical research and clinical practice in cancer. He pioneered the first clinical trial in the use of adenovirus and plasmid for the treatment of liver cancer, as well as the use of plasmid gene therapy in hydrodynamic gene delivery. Nagy is a founder and was the Head of R&D of MiNA Therapeutics. Whilst at MiNA he was driving the development of an saRNA drug (a new class of medicines) which is currently being trialled in patients with liver cancer in eight UK centres, and sites in Singapore and Taiwan (OUTREACH study, ClinicalTrials.gov ID NCT02716012) and in a second trial in patients with solid tumours (TIMEPOINT study, ClinicalTrials.gov ID NCT 04105335) in the UK, USA, Europe, Singapore and Taiwan. He has published widely in gene therapy, stem cell therapy, oligonucleotides, endoscopy and surgery. Currently he is the CEO of Apterna Limited, a company focussed on novel oligonucleotide deliver. Previously Nagy was founder and Chairman of EMcision Limited (acquired by Boston Scientific Inc in 2018). Nagy is Lead Clinician and Head of the Department of HPB Surgery at Imperial College London.

Raquel Loga is the Coordinator at the Center for Health & Well-being at IE University. With an interdisciplinary background in philosophy, psychology, and politics, she specializes in the intersection of mental well-being and public policy. Before joining the Center, she has worked as a Financial Consultant at EY, a Public Affairs Consultant at Kreab Worldwide, and a Project Manager at Future Policy Lab, specializing in ESG, EU regulation, and policy research. She also worked as a Research Assistant at New York University, focusing on political theory, and has contributed to mental health advocacy as an Advisor at Youth-GEMs and Youth-Reach. Raquel holds a Master’s Degree in Philosophy from the University of Barcelona, a Bachelor's in Global Studies from Universitat Pompeu Fabra and Sciences Po, and a Minor in Law from Universitat Oberta de Catalunya. She is currently completing a Bachelor’s in Psychology. Her work focuses on advancing innovative approaches to mental well-being and societal resilience.

Dr. Ben A. Sutter has been studying and treating TMJ dysfunction since graduating Rutgers School of Dental Medicine in 2005. He completed a General Practice Residency at Overlook Hospital in Summit, NJ in 2006, and currently practices General Dentistry as a solo private practice owner in Eugene, OR. Dr. Sutter sought out advanced education and training to treat both Neuromuscular issues and Dental Occlusion. He completed studies at the Las Vegas Institute, the Piper Education and Research Center, the Perfect Bite Doctor, at TruDenta, and with Equilibration Seminars. He has earned Fellowship status from the Academy of General Dentistry, the Las Vegas Institute, and the Center for Neural Occlusion. And Dr. Sutter is a Diplomate of the American Board of Laser Surgery and was awarded Mastership in the International College of Craniomandibular Orthopedics. He is an Adjunctive Professor at UNLV School of Dental Medicine and Faculty at the Vivos Institute.. He authored and/or co-authored over 40 peer reviewed articles and abstracts on Digital Occlusion and Disclusion Time Reduction (DTR). Most notably is a book chapter he authored three chapters in the Handbook of Research on Clinical Applications of Computerized Occlusal Analysis in Dental Medicine. A cornerstone of his practice is the diagnosis and effective treatment of Trigeminal Neuralgia without surgery or medications. He has served as the Editor in Chief of Advanced Dental Techniques and Technologies since the journal’s inception in 2018.

Mohammad Ghasemi Hamed, the innovative co-founder of Odyssey Neuroscience, is at the forefront of cognitive enhancement technology. His startup is pioneering the integration of personalized Transcranial Electrical Stimulation (TES) with advanced AI algorithms. Holding a Ph.D. in Computer Science and boasting extensive expertise in statistical learning and data science, Mohammad has adeptly bridged the gap between academic research and entrepreneurial innovation. His groundbreaking work has culminated in the creation of the world's first AI-powered, individualized cognitive enhancement platform. Drawing from his background as an AI researcher, Mohammad infuses scientific precision with entrepreneurial vision in the realm of neurotechnology. His passionate pursuit of unlocking human cognitive potential offers unique insights at the convergence of neuroscience, artificial intelligence, and the optimization of human performance.

Dr. Horng-Dar Wang currently is a Professor and Chairman in the Department of Life Science and the Institute of Biotechnology and an adjunct Professor in both the Institute of Systems Neuroscience and Department of Life Science at National Tsing Hua University in Taiwan. Dr. Wang previously served as a Director at the Institute of Biotechnology from 2015 to 2021. Dr. Wang received his Ph.D. degree from Department of Molecular Pharmacology and Toxicology at the University of Southern California and did his post-doctoral scholar with Professor Seymour Benzer in the Biology Division at California Institute of Technology.His research interest focuses on the identification of novel genes to extend lifespan and promote healthspan in Drosophila and C. elegans, and applying the anti-aging gene effect on neurodegeneration and cancer research. Several longevity related genes have been identified not only able to extend lifespan but also prevent neurodegeneration and cancer proliferation.

Prof. Girijesh Prasad is Professor of Intelligent Systems in the School of Computing, Engineering and Intelligent Systems, Ulster University (UU), UK. He is Director of Northern Ireland Functional Brain Mapping (NIFBM) facility at UU’s Intelligent Systems Research Centre (ISRC), where he leads the Cognitive Neuroscience and Neurotechnology research team. He received a BTech in Electrical Engineering from Regional Engineering College (now National Institute of Technology) Calicut, India in 1987, an MTech in Computer Science and Technology from University of Roorkee (now Indian Institute of Technology Roorkee), India in 1992, and a PhD in Electrical Engineering from Queen's University of Belfast, UK in 1997. He is a Chartered Engineer, a Fellow of IET, a Fellow of Higher Education Academy, a Senior Member of IEEE, and a founder member of IEEE Systems, Man, and Cybernetics society’s Technical Committee on Brain-Machine Interface Systems. In 2017, he was awarded the Fellowship of International Academy of Physical Sciences (IAPS) India, and the Senior Distinguished Research Fellowship of Ulster University. Prof. Prasad joined Ulster University, as a Lecturer in 1999; he was promoted to Senior Lecturer in 2007, Reader in 2008, and Professor in 2011. Previously he worked in industry first as a Digital Systems Engineer and then as a Power Plant Engineer in India, and as a Research Fellow on an EPSRC/industry project at Queen’s University of Belfast, UK. His research interests are in intelligent systems, data engineering, brain modelling, brain-computer interface (BCI) & neuro-rehabilitation, and assistive technology. Under his supervision, an advanced rehabilitation protocol has been developed incorporating an active physical practice stage followed by a mental practice stage, using a neuro-rehab system consisting of a robotic hand exoskeleton and an EEG/EEG-EMG based BCI, which has been trialled on groups of chronic stroke patients in UK as well as India, resulting in transformative change in patients’ quality of life. He has published over 300 research papers in journals, edited books, and conference proceedings. He has supervised to completion 22 PhD students. His research has attracted 18 research grant awards amounting to over £10M funding from national and international agencies including Invest Northern Ireland, Department of Employment and Learning, Research Councils UK (RCUK), Leverhulme Trust, Royal Society, UK India Education and Research Initiative (UKIERI), UK Research and Innovation (UKRI) and Irish industry.

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior, he was an Erasmus Student at Faculté de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hiredasaPostdoctoralScholarintheDepartmentofPharmacologyandPhysiologyatthe UniversityofSouthFloridainTampa,ontworesearchgrantsfundedbytheOfficeofNavalResearch(USNavy) and Divers’ Alert Network. He has written and lectured widelyworldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters.

Dr. Mohita Shrivastava, Ph.D is an internationally trained Neuroscientist & Founder & CEO of the Cognitome Program, Cognitome LLC, Dubai. She holds a Ph.D. degree in the field of Neurosciences from Neurosciences Centre, AIIMS, New Delhi, India & her Ph.D research training from Kansas University Medical Centre, Kansas, USA. She holds two master’s degrees one in Biomedical Sciences from Dr, BR Ambedkar Centre for Biomedical Research, University of Delhi and other in Applied Clinical Psychology from Annamalai University. She also holds an Advanced PG Diploma in Applied Neuropsychology from the University of Bristol, United Kingdom. With more than a decade of experience in the industry, Dr. Shrivastava has been involved in Neuroscience and Neuropsychology teaching, research, therapeutics, projects, and outreach. She is the editorial board member for internationally acclaimed neuroscience journals & holds active membership of several esteemed international neuroscience societies dedicated to research and development in neurosciences. She has published peer-reviewed articles in international journals and columns on mental health in leading newspapers and magazines such as Khaleej Times (UAE’s National Daily), WKND Magazine and Passion Vista Global Magazine. Throughout her illustrious career, Dr. Shrivastava has received many awards and accolades and has been recently selected as Top Neuroscientist of the Year 2024 by the International Association of Top Professionals (IAOTP), NY, USA for her outstanding leadership, dedication, and commitment to the industry. She has also been awarded Global Mental Health Advocacy Leadership Award by Integrated Health & Wellness Council @10th IHW Summit in September 2024, Dubai. Dr. Shrivastava has been conferred with Outstanding Leadership Award in June 2023 and Visionaries Award in February 2024 in Dubai, UAE by Health 2.0 conferences. The Cognitome Program, a structured, neuroscientific, and holistic program, led by Dr. Shrivastava is a pioneering initiative effectively addresses issues related with cognition, cognitive impairment and age-related cognitive decline and offer therapeutic interventions and management for a wide range of brain and behavioral issues. By combining principles of neuroscience and neuropsychology, the program helps individuals tap into the brain's resources, by exploiting the concept of neuroplasticity and enabling personal and professional growth at any age or stage of life. The Cognitome Program, Cognitome LLC has been conferred with Outstanding Organization Award in Las Vegas, USA 2024 by Health 2.0 Conferences.

I have a B.A. from UCSD in communications, and M.A. from USIU in Human Behavior and pursued a Ph.d. from MIT in community development. I am the traditional leader for 17 American Indian Reservations in Southern California. I have had extensive professional work experience in a variety of fields and areas. I have had extensive experiences in healing of trauma within the American Indian communities.

Dr. SARA ABIDAR is a PhD researcher in neurobiology. Sara defended her PhD in Biochemistry-Neurosciences in 2021 at the Faculty of Sciences and Technology of Tangier, after a master’s degree in Techniques and Experimental Methodologies of Biotechnology in 2015 and a bachelor’s degree in Biological Engineering in 2013 at the same university. Sara focused on the neuroprotective effects of Ceratonia siliqua L. (carob) against Parkinson’s disease induced in rodents and zebrafish. To achieve her goals, Sara has, in 2018, received the Eugen Ionescu scholarship to pursue her experiments at the Faculty of Biology at the University Alexandru Ioan Cuza of Iasi in Romania. In 2019, Sara chased her dreams in the United States as she received the Fulbright scholarship, which allowed her to consolidate her research at the Department of Biology of the University of Arizona, Tucson. Sara published her research in prestigious journals and received an innovation award for her promising results in Morocco. Sara is an assistant editor for the journal Neurological Research (Taylor & Francis) and currently an associate member at the Laboratory of Biochemistry and Molecular Genetics, where she conducts research about the neuroprotective effects of phytochemicals against neurodegenerative disorders, particularly Alzheimer’s and Parkinson’s diseases, in collaboration with different international research institutions.

I am Dr. Hamza G. Adamu, a passionate anatomist and committed biomedical researcher with a solid academic foundation in the field of human anatomy. I earned my Bachelor’s, Master’s, and Doctoral degrees (B.Sc., M.Sc., and Ph.D.) in Human Anatomy from Ahmadu Bello University, Zaria; one of Nigeria’s leading institutions. My scholarly interests encompass various subfields of anatomy, including neuroanatomy, histology, and toxicology. A significant part of my research is devoted to exploring the mechanisms of neuroprotection and the role of glial cells in response to toxic and pathological insults to the nervous system.